Diclofenac-Solofarm, eye drops 0.1% 5 ml

Conjunctivitis, Corneal injuries, Cataract, Pain after injuries and operations, Pain, Inflammatory eye diseases – Inhibition of miosis during cataract surgery (the drug has no mydriatic properties and does not replace standard drugs that cause pupil dilation);
– Treatment and prevention of inflammatory processes after surgical interventions on the eyeball;
– prophylaxis of cystic edema of the macula after cataract operations;
– treatment of non-infectious conjunctivitis;
– treatment and prophylaxis of post-traumatic inflammatory process after penetrating and non-penetrating eyeball wounds (in addition to local antibacterial therapy).

Active ingredient

How to take, the dosage

Interaction

Conjunctival injection of NSAIDs, including diclofenac, together with glucocorticosteroids (GCS) in patients with severe corneal inflammation may lead to progression of corneal damage. Caution should be exercised when using the drug together with GCS in patients with severe corneal inflammation.

If necessary, other eye drops including those containing GKS may be used concomitantly. If necessary, a break of at least 5 minutes needs to be taken between doses in order to prevent washout of the active ingredient in subsequent doses.

Special Instructions

Contraindications

Side effects

The undesired phenomena presented below are listed according to frequency of occurrence. The frequency of occurrence is defined as follows: very frequently (≥1/10), frequently (≥1/100 and < 1/10), infrequently (≥1/1000 and < 1/100), rarely (≥1/10000 and < 1/1000), very rarely (< 1/10000, including individual cases).

Often: Temporary mild to moderate eye irritation.

Infrequent: itchy eyes, conjunctival hyperemia, and blurred vision (immediately after injection).

Rarely: pitting keratitis or corneal lesions (after repeated use of the drug). In patients at risk of corneal lesions, e.g., when using glucocorticosteroids or as a result of various diseases (infections, rheumatoid arthritis), repeated use of the drug may rarely cause sight-threatening complications: ulcerative or pitting keratitis, corneal epithelial defects, corneal edema and thinning.

Very rare: dyspnea and worsening of the course of bronchial asthma, pain in the eyes.

Allergic reactions

Rarely: conjunctival hyperemia, allergic conjunctivitis, redness, itching and swelling of the eyelids, urticaria, rash, eczema, erythema, itching, hypersensitivity, cough and rhinitis.

Overdose

Similarities